Skip to main content

Table 2 MAF distribution among the current Emirati cohort

From: The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population

Genetic variants

MAF (%)

P value

X2

CYP2C19

   

 rs4244285 (CYP2C19*2)

19.3

0.054

3.78

 rs4986893 (CYP2C19*3)

0.4

0.558

0.841

 rs1224856(CYP2C19*17)

19.7

0.963

232.05

 rs12769205 (CYP2C19 *2/*35)

20.5

0.558

0.345

ABCB1

   

 rs1045642

55.9

0.154

7.327

 rs2032582

55.5

0.257

7.664

 rs1128503

55.46

0.374

9.899

PON1

   

 rs662 (Q192R)

38.6

0.088

34.502

 rs854560 (L55M)

32.03

0.382

77.641

P2Y12R

   

 rs6785930 (C34T)

27.12

0.551

92.199

 rs6809699 (G52T)

95.94

0.4861

420.716

  1. MAF, minor allele frequency